Lyndsey A Reich Selected Research

Neoplasm Antigens (Tumor Antigens)

1/2017

Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lyndsey A Reich Research Topics

Disease

6	Neoplasms (Cancer) 02/2023 - 01/2017
3	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2022 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2019
1	Inflammation (Inflammations) 12/2020
1	Hypertriglyceridemia 12/2020
1	Triple Negative Breast Neoplasms 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017

Drug/Important Bio-Agent (IBA)

5	Bexarotene (LGD1069)FDA Link 02/2023 - 01/2019
4	Retinoid X Receptors (Retinoid X Receptor)IBA 02/2023 - 01/2019
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2023 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
1	RNA (Ribonucleic Acid)IBA 02/2023
1	LigandsIBA 01/2022
1	LG 268IBA 01/2019
1	AntibodiesIBA 01/2019
1	LG 100268IBA 01/2019
1	Cancer VaccinesIBA 01/2017
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2017
1	TG4010IBA 01/2017
1	VaccinesIBA 01/2017

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2017
1	Immunomodulation 01/2021
1	Radiotherapy 01/2017
1	Injections 01/2017